Education
About Us
Working with TipRanks
Follow Us
CanSino Biologics, Inc. Class H (HK:6185)
:6185
Comparison Results
CanSino Biologics, Inc. Class H
HK$44.94
HK$12.30B
―
33.53%
1 Buy
0 Hold
0 Sell
Moderate Buy
Guangzhou Baiyunshan Pharmaceutical Holdings Company
HK$19.06
$44.96B
9.63
10.30%
0 Buy
0 Hold
0 Sell
Moderate Sell
Livzon Pharmaceutical Group
HK$30.94
HK$33.36B
12.10
19.62%
0 Buy
0 Hold
1 Sell
Moderate Sell
Shanghai Fosun Pharmaceutical (Group) Co
HK$21.32
$77.88B
17.22
51.16%
1 Buy
1 Hold
1 Sell
Hold
China Resources Pharmaceutical Group Ltd.
HK$4.85
€31.10B
10.23
-6.68%
1 Buy
0 Hold
0 Sell
Moderate Buy
Hansoh Pharmaceutical Group Company Limited
HK$40.48
HK$216.05B
41.10
116.35%
7 Buy
1 Hold
0 Sell
Strong Buy
Performance Comparison
HK:6185
CanSino Biologics, Inc. Class H
40.06
10.06
33.53%
HK:0874
Guangzhou Baiyunshan Pharmaceutical Holdings Company
19.06
1.78
10.30%
HK:1513
Livzon Pharmaceutical Group
31.00
5.23
20.29%
HK:2196
Shanghai Fosun Pharmaceutical (Group) Co
21.32
7.18
50.75%
HK:3320
China Resources Pharmaceutical Group Ltd.
4.85
-0.35
-6.68%
HK:3692
Hansoh Pharmaceutical Group Company Limited
40.48
21.47
112.94%